Bank of New York Mellon’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $84M | Sell |
3,411,532
-398,356
| -10% | -$9.21M | 0.01% | 761 |
|
|
2026
Q1 | $91.2M | Sell |
3,809,888
-104,926
| -3% | -$2.56M | 0.02% | 684 |
|
|
2025
Q4 | $88.6M | Sell |
3,914,814
-1,216,302
| -24% | -$26.5M | 0.02% | 710 |
|
|
2025
Q3 | $103M | Buy |
5,131,116
+3,359,862
| +190% | +$56.3M | 0.02% | 627 |
|
|
2025
Q2 | $25.3M | Sell |
1,771,254
-188,630
| -10% | -$2.2M | ﹤0.01% | 1394 |
|
|
2025
Q1 | $20.6M | Sell |
1,959,884
-47,745
| -2% | -$540K | ﹤0.01% | 1488 |
|
|
2024
Q4 | $24.3M | Sell |
2,007,629
-69,504
| -3% | -$909K | ﹤0.01% | 1461 |
|
|
2024
Q3 | $30.5M | Sell |
2,077,133
-212,783
| -9% | -$2.96M | 0.01% | 1327 |
|
|
2024
Q2 | $33M | Buy |
2,289,916
+17,486
| +0.8% | +$279K | 0.01% | 1279 |
|
|
2024
Q1 | $37M | Buy |
2,272,430
+25,076
| +1% | +$392K | 0.01% | 1222 |
|
|
2023
Q4 | $33.5M | Buy |
2,247,354
+398,420
| +22% | +$4.51M | 0.01% | 1306 |
|
|
2023
Q3 | $20.8M | Buy |
1,848,934
+124,225
| +7% | +$1.44M | ﹤0.01% | 1518 |
|
|
2023
Q2 | $17.4M | Sell |
1,724,709
-239,682
| -12% | -$2.22M | ﹤0.01% | 1626 |
|
|
2023
Q1 | $18.5M | Sell |
1,964,391
-51,422
| -3% | -$607K | ﹤0.01% | 1589 |
|
|
2022
Q4 | $24.6M | Sell |
2,015,813
-901,643
| -31% | -$11.2M | 0.01% | 1422 |
|
|
2022
Q3 | $36.2M | Sell |
2,917,456
-90,828
| -3% | -$1.59M | 0.01% | 1154 |
|
|
2022
Q2 | $59.1M | Sell |
3,008,284
-3,225,470
| -52% | -$76.3M | 0.01% | 875 |
|
|
2022
Q1 | $163M | Buy |
6,233,754
+304,625
| +5% | +$8.11M | 0.03% | 472 |
|
|
2021
Q4 | $168M | Sell |
5,929,129
-382,456
| -6% | -$11.9M | 0.03% | 483 |
|
|
2021
Q3 | $201M | Buy |
6,311,585
+2,334,220
| +59% | +$78.3M | 0.04% | 405 |
|
|
2021
Q2 | $138M | Sell |
3,977,365
-29,322
| -0.7% | -$967K | 0.03% | 550 |
|
|
2021
Q1 | $118M | Buy |
4,006,687
+283,620
| +8% | +$8.72M | 0.02% | 626 |
|
|
2020
Q4 | $114M | Buy |
3,723,067
+2,137,917
| +135% | +$65.2M | 0.02% | 599 |
|
|
2020
Q3 | $44.3M | Buy |
1,585,150
+116,809
| +8% | +$2.96M | 0.01% | 990 |
|
|
2020
Q2 | $31.5M | Buy |
1,468,341
+47,779
| +3% | +$1.06M | 0.01% | 1159 |
|
|
2020
Q1 | $31.8M | Buy |
1,420,562
+37,698
| +3% | +$1.03M | 0.01% | 1012 |
|
|
2019
Q4 | $40.7M | Sell |
1,382,864
-201,056
| -13% | -$5.46M | 0.01% | 1105 |
|
|
2019
Q3 | $42.1M | Buy |
1,583,920
+96,437
| +6% | +$2.89M | 0.01% | 1050 |
|
|
2019
Q2 | $50.3M | Buy |
1,487,483
+270,351
| +22% | +$8.78M | 0.01% | 973 |
|
|
2019
Q1 | $39M | Buy |
1,217,132
+1,146,952
| +1,634% | +$35.3M | 0.01% | 1119 |
|
|
2018
Q4 | $2.21M | Buy |
+70,180
| New | +$2.3M | ﹤0.01% | 2673 |
|
Other funds holding ELAN
Bank of New York Mellon's ELAN Position: Q2 2026 in Review
Bank of New York Mellon reduced its Elanco Animal Health (ELAN) stake by 10% in Q2 2026, selling an estimated $9.21M and leaving 3,411,532 shares worth $84M. The position accounts for 0.01% of the portfolio, ranked #761.
Bank of New York Mellon first reported a position in ELAN in Q4 2018 and has held it in 31 quarters since. The position peaked at $201M in Q3 2021. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.
- Bank of New York Mellon held 3,411,532 shares of Elanco Animal Health worth $84M as of Q2 2026.
- Bank of New York Mellon sold 398,356 Elanco Animal Health shares in Q2 2026, an estimated $9.21M.
- Elanco Animal Health made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #761 holding.
- Bank of New York Mellon first reported a position in Elanco Animal Health in Q4 2018 and has held it in 31 quarters since.
- Bank of New York Mellon's Elanco Animal Health position peaked at $201M in Q3 2021.
- 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.